Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theralase Technologies Inc.
V.TLT.W
Primary Symbol:
V.TLT
Alternate Symbol(s):
TLTFF
Healthcare
Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called...
Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:TLT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Apr 25, 2024 6:45pm
RE:RE:RE:RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
https://stockhouse.com/news/press-releases/2024/04/25/immunitybio-announces-positive-overall-survival-results-of-anktiva-combined-with
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Apr 25, 2024 6:32pm
RE:RE:RE:RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
So nice you think btd is baked in at .16 for tlt. ?
Fresh Insight into the Topaz Helium Project's Expected Size and Scale
posted Apr 26, 2024 9:00am by
Pulsar Helium Inc.
-
|
The prospective zone is very broad. We believe its not just an isolated occurrence but is actually something quite regionally extensive ...read more
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Apr 25, 2024 6:29pm
RE:RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
Hi DDW or RDW whatever 17,250,000 $ somebody not going to be happy.Personal disclaimer I got no leg in that.
(996)
•••
enriquesuave
X
View Profile
View Bullboard History
Comment by
enriquesuave
on Apr 25, 2024 6:07pm
RE:RE:RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
FDA approval was already baked in for IBRX, IMHO. Market Cap is at $3.72 Billion USD. 100 times more than ours. Like us being at 15-18$ US
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:24pm
@ the Bell: Tech drop takes a bite out of the TSX
Technology shares led the decliners as the sector endured its worst day in more than a month on the TSX, dragged down by crypto miners.
read article.
(19)
•••
hilles
X
View Profile
View Bullboard History
Comment by
hilles
on Apr 25, 2024 4:19pm
RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
They accepted my money. I'm a drop of water in the lake. Hilles
(170)
•••
Dumbeldorfwhite
X
View Profile
View Bullboard History
Comment by
Dumbeldorfwhite
on Apr 25, 2024 4:11pm
RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
Hahahaha don't tell the good ole boys club that, u might get sued!
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Apr 25, 2024 3:59pm
RE:RE:RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
Somebody having a field day after the announced pp Historical Short Volume Data for TLTFF Date Close High Low Volume Short Volume
...more
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Apr 25, 2024 3:56pm
RE:RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
Ibrx in 2 days of trading after receiving btd gained approximately 10% $5.16 0.3399 | 7.05% Bid: 5.15 x 2,600 Ask: 5.16 x
...more
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Apr 25, 2024 3:40pm
RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
AUG 2019 warrants expiring 2024.That's a huge nr 4 monts to go. Company issued 57,500,000 units of the Company (including the exercise in full of the over-allotment option
...more
(406)
•••
CAinPlap
X
View Profile
View Bullboard History
Comment by
CAinPlap
on Apr 25, 2024 3:38pm
RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
May I as respectfully as possible ask anyone thinking the company turned anyone's money away to please pull their head out of the sand.
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Apr 25, 2024 3:28pm
RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see
16 investors cought up around 47 thousand $ average for 750 thou i think the minimum participation for pp was 18 thou for accredited investors.Me thinking somebody is fool or smart?
(48)
•••
managementfirst
X
View Profile
View Bullboard History
Comment by
managementfirst
on Apr 25, 2024 1:20pm
RE:RE:FDA Approval Must Come
Clinical trial is very expensive, most time cost several 100 millions. For big pharms those money is not difficult, but for a small company at initial stage like TLT it is too hard to perform. This
...more
(248)
•••
Galaxym31
X
View Profile
View Bullboard History
Comment by
Galaxym31
on Apr 25, 2024 12:42pm
RE:FDA Approval Must Come
I have been liking since 2015 . How about a name change to reflect the future . Future Technologies FT , or Cancer Killer . CK , Now and Beyond Technologies NBT .
(130)
•••
menoalittle
X
View Profile
View Bullboard History
Comment by
menoalittle
on Apr 25, 2024 12:31pm
RE:RE:RE:April 29, Next Monday expecting an annual report, will see
If there were only 16 placees, seems quite low to me. Was anyone shut out that thought they were going to be in? And how many of those placees were insiders? Maybe they only took in as much money as
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Exploration company provides project portfolio update
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale